Risks and burdens of incident diabetes in long COVID: a cohort study
Xie Y, Al-Aly Z
Lancet Diabetes Endocrinol. 2022;10(5):311-21.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: A meta-analysis and meta-regression analysis
Yoshiji S, Minamino H, Tanaka D, et al.
Diabetes Obes Metab. 2022;24(6):1029-37.
Leggi
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
Waijer SW, Vart P, Cherney DZI, et al.
Diabetologia. Pub. online 21 Apr 2022.
Leggi
Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study
Soulimane S, Balkau B, Vogtschmidt YD, et al.
Diabetologia. Pub. online 12 Apr 2022
Leggi
Impact of SGLT2 Inhibitors on Serum Sodium in Heart Failure With Reduced Ejection Fraction∗
Li S, Levy WC
J Am Coll Cardiol HF. Pub. online 06 Apr 2022
Leggi
CAPTURE: A cross-sectional study on the prevalence of cardiovascular disease in adults with type 2 diabetes in Italy
Russo GT, Corigliano G, Arturi F, et al.
Nutr Metab Cardiovasc Dis. 2022;32(5):1195-1201
Leggi
Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
Li N, Tan H, Xie A, et al.
BMC Endocrine Disorders. 2022;22(1):101
Leggi
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
Tamborlane WV, Laffel LM, Shehadeh N, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00052-3
Leggi
Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized controlled trials
Neuen BL, Oshima M, Agarwal R, et al.
Circulation. Pub. online 8 Apr 2022
Leggi
Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial
Renard E, Riveline JP, Hanaire H, et al.
Diabetes Obes Metab. 2022;24(5):859-867
Leggi